Asiatic acid ameliorates tubulointerstitial fibrosis in mice with ureteral obstruction

Xu,Changgeng; Wang,Wei; Xu,Mingwei; Zhang,Jie

doi:10.3892/etm.2013.1197

Asiatic acid ameliorates tubulointerstitial fibrosis in mice with ureteral obstruction

Authors:
- Changgeng Xu
- Wei Wang
- Mingwei Xu
- Jie Zhang
View Affiliations

Affiliations: Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China
Published online on: July 2, 2013 https://doi.org/10.3892/etm.2013.1197
Pages: 731-736

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Asiatic acid (AA) is one of the triterpenoid compounds present in Centella asiatica and it has been shown to be capable of attenuating liver fibrosis. In the present study, we investigated the effects of AA on renal tubulointerstitial fibrosis in mice with unilateral ureteral obstruction (UUO). Mice were divided randomly into five groups (n=5 per group): the sham‑surgery (Sh), UUO plus vehicle treatment (UUO+V), UUO plus 1 mg/kg body weight AA treatment (UUO+A1), UUO plus 4 mg/kg body weight AA treatment (UUO+A2) and UUO plus 16 mg/kg body weight AA treatment (UUO+A3) groups. The mice were treated with AA daily by oral gavage from the day subsequent to surgery for six days. On the seventh day, the mice were sacrificed for examination. Tubular injury was observed in the renal cortex of the mice administered the vehicle, while high doses of AA were observed to exert a significant suppressive effect on tubular injury. Interstitial fibrosis, increased expression of α‑smooth muscle actin (SMA) and transforming growth factor (TGF)‑β1 and phosphorylation of Smad2/3 were induced by ureteral ligation; however these effects were abrogated by intermediate and high doses of AA. These results suggest that AA may ameliorate tubulointerstitial fibrosis by reducing tubular injury, fibroblast activation and extracellular matrix (ECM) accumulation mediated by Smad‑dependent TGF‑β1 signaling.

View Figures

View References

1	Collins AJ, Foley RN, Chavers B, et al: United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis. 59(Suppl 1): A7e1–e420. 2012. View Article : Google Scholar : PubMed/NCBI
2	Yanagita M: Inhibitors/antagonists of TGF-beta system in kidney fibrosis. Nephrol Dial Transplant. 27:3686–3691. 2012. View Article : Google Scholar : PubMed/NCBI
3	Hodgkins KS and Schnaper HW: Tubulointerstitial injury and the progression of chronic kidney disease. Pediatr Nephrol. 27:901–909. 2012. View Article : Google Scholar : PubMed/NCBI
4	Formentini I, Bobadilla M, Haefliger C, et al: Current drug development challenges in chronic kidney disease (CKD) - identification of individualized determinants of renal progression and premature cardiovascular disease (CVD). Nephrol Dial Transplant. 27(Suppl 3): iii81–iii88. 2012.
5	Barnes JL and Glass WF II: Renal interstitial fibrosis: a critical evaluation of the origin of myofibroblasts. Contrib Nephrol. 169:73–93. 2011. View Article : Google Scholar : PubMed/NCBI
6	Grande MT and López-Novoa JM: Fibroblast activation and myofibroblast generation in obstructive nephropathy. Nat Rev Nephrol. 5:319–328. 2009. View Article : Google Scholar : PubMed/NCBI
7	Strutz F and Zeisberg M: Renal fibroblasts and myofibroblasts in chronic kidney disease. J Am Soc Nephrol. 17:2992–2998. 2006. View Article : Google Scholar : PubMed/NCBI
8	López-Hernández FJ and López-Novoa JM: Role of TGF-beta in chronic kidney disease: an integration of tubular, glomerular and vascular effects. Cell Tissue Res. 347:141–154. 2012.PubMed/NCBI
9	Verrecchia F and Mauviel A: Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J Invest Dermatol. 118:211–215. 2002. View Article : Google Scholar : PubMed/NCBI
10	Santibañez JF, Quintanilla M and Bernabeu C: TGF-beta/TGF-beta receptor system and its role in physiological and pathological conditions. Clin Sci (Lond). 121:233–251. 2011.PubMed/NCBI
11	Lan HY: Diverse roles of TGF-β/Smads in renal fibrosis and inflammation. Int J Biol Sci. 7:1056–1067. 2011.
12	Kavitha CV, Agarwal C, Agarwal R and Deep G: Asiatic acid inhibits pro-angiogenic effects of VEGF and human gliomas in endothelial cell culture models. PLoS One. 6:e227452011. View Article : Google Scholar : PubMed/NCBI
13	Lee KY, Bae ON, Serfozo K, et al: Asiatic acid attenuates infarct volume, mitochondrial dysfunction, and matrix metalloproteinase-9 induction after focal cerebral ischemia. Stroke. 43:1632–1638. 2012.PubMed/NCBI
14	Tang LX, He RH, Yang G, et al: Asiatic acid inhibits liver fibrosis by blocking TGF-beta/Smad signaling in vivo and in vitro. PLoS One. 7:e313502012. View Article : Google Scholar : PubMed/NCBI
15	Zhang X, Wu J, Dou Y, et al: Asiatic acid protects primary neurons against C2-ceramide-induced apoptosis. Eur J Pharmacol. 679:51–59. 2012. View Article : Google Scholar : PubMed/NCBI
16	Eddy AA, López-Guisa JM, Okamura DM and Yamaguchi I: Investigating mechanisms of chronic kidney disease in mouse models. Pediatr Nephrol. 27:1233–1247. 2012. View Article : Google Scholar : PubMed/NCBI
17	Grande MT, Fuentes-Calvo I, Arévalo M, et al: Deletion of H-Ras decreases renal fibrosis and myofibroblast activation following ureteral obstruction in mice. Kidney Int. 77:509–518. 2010. View Article : Google Scholar : PubMed/NCBI
18	Fujiu K, Manabe I and Nagai R: Renal collecting duct epithelial cells regulate inflammation in tubulointerstitial damage in mice. J Clin Invest. 121:3425–3441. 2011. View Article : Google Scholar : PubMed/NCBI
19	Sörensen I, Susnik N, Inhester T, et al: Fibrinogen, acting as a mitogen for tubulointerstitial fibroblasts, promotes renal fibrosis. Kidney Int. 80:1035–1044. 2011.PubMed/NCBI
20	Barnes JL and Gorin Y: Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases. Kidney Int. 79:944–956. 2011. View Article : Google Scholar : PubMed/NCBI
21	Prunotto M, Budd DC, Gabbiani G, et al: Epithelial-mesenchymal crosstalk alteration in kidney fibrosis. J Pathol. 228:131–147. 2012. View Article : Google Scholar : PubMed/NCBI
22	Zeisberg M and Neilson EG: Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol. 21:1819–1834. 2010. View Article : Google Scholar
23	Mimura I and Nangaku M: The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease. Nat Rev Nephrol. 6:667–678. 2010. View Article : Google Scholar : PubMed/NCBI
24	Loeffler I, Liebisch M and Wolf G: Collagen VIII influences epithelial phenotypic changes in experimental diabetic nephropathy. Am J Physiol Renal Physiol. 303:F733–F745. 2012. View Article : Google Scholar : PubMed/NCBI
25	Schaefer L: Extracellular matrix molecules: endogenous danger signals as new drug targets in kidney diseases. Curr Opin Pharmacol. 10:185–190. 2010. View Article : Google Scholar : PubMed/NCBI
26	Boor P and Floege J: The renal (myo-)fibroblast: a heterogeneous group of cells. Nephrol Dial Transplant. 27:3027–3036. 2012. View Article : Google Scholar : PubMed/NCBI
27	Boor P, Ostendorf T and Floege J: Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol. 6:643–656. 2010. View Article : Google Scholar : PubMed/NCBI
28	Gewin L and Zent R: How does TGF-beta mediate tubulointerstitial fibrosis? Semin Nephrol. 32:228–235. 2012. View Article : Google Scholar : PubMed/NCBI
29	Meng XM, Chung AC and Lan HY: Role of the TGF-beta/BMP-7/Smad pathways in renal diseases. Clin Sci (Lond). 124:243–254. 2013. View Article : Google Scholar : PubMed/NCBI